Literature DB >> 12500050

The design of prophylactic trials for HIV: the case of microbicides.

Zena A Stein1, Landon Myer, Mervyn Susser.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12500050     DOI: 10.1097/00001648-200301000-00018

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


× No keyword cloud information.
  4 in total

Review 1.  Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions.

Authors:  A M Minnis; N S Padian
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

2.  Integrating behavioral and social science research into microbicide clinical trials: challenges and opportunities.

Authors:  Elizabeth E Tolley; Lawrence J Severy
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

Review 3.  Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.

Authors:  Miriam Hartmann; Michele Lanham; Thesla Palanee-Phillips; Florence Mathebula; Elizabeth E Tolley; Dean Peacock; Laura Pascoe; Seth Zissette; Sarah T Roberts; Danielle Wagner; Ellen Wilson; Asha Ayub; Rose Wilcher; Elizabeth T Montgomery
Journal:  AIDS Educ Prev       Date:  2019-10

4.  Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study.

Authors:  Ellen K Wilson; L Danielle Wagner; Thesla Palanee-Phillips; Sarah T Roberts; Elizabeth E Tolley; Florence Mathebula; Laura Pascoe; Michele Lanham; Rose Wilcher; Elizabeth T Montgomery
Journal:  BMC Womens Health       Date:  2021-03-25       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.